Table of Contents

1 Study Coverage

• 1.1 Radiation Oncology Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Radiation Oncology Market Size Growth Rate by Product
  • 1.4.2 External Beam Radiation Therapy (EBRT)
  • 1.4.3 Brachytherapy
• 1.5 Market by End User
  • 1.5.1 Global Radiation Oncology Market Size Growth Rate by End User
  • 1.5.2 Blood Cancer (Leukaemia)
  • 1.5.3 Breast Cancer
  • 1.5.4 Gastrointestinal Cancer
  • 1.5.5 Respiratory/Lung Cancer
  • 1.5.6 Skin Cancer
  • 1.5.7 Other Cancers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Radiation Oncology Market Size
  • 2.1.1 Global Radiation Oncology Revenue 2014-2025
  • 2.1.2 Global Radiation Oncology Sales 2014-2025
• 2.2 Radiation Oncology Growth Rate by Regions
  • 2.2.1 Global Radiation Oncology Sales by Regions
  • 2.2.2 Global Radiation Oncology Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Radiation Oncology Sales by Manufacturers
  • 3.1.1 Radiation Oncology Sales by Manufacturers
  • 3.1.2 Radiation Oncology Sales Market Share by Manufacturers
  • 3.1.3 Global Radiation Oncology Market Concentration Ratio (CR5 and HHI)
• 3.2 Radiation Oncology Revenue by Manufacturers
  • 3.2.1 Radiation Oncology Revenue by Manufacturers (2014-2019)
  • 3.2.2 Radiation Oncology Revenue Share by Manufacturers (2014-2019)
• 3.3 Radiation Oncology Price by Manufacturers
• 3.4 Radiation Oncology Manufacturing Base Distribution, Product Types
  • 3.4.1 Radiation Oncology Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Radiation Oncology Product Type
  • 3.4.3 Date of International Manufacturers Enter into Radiation Oncology Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Radiation Oncology Sales by Product
• 4.2 Global Radiation Oncology Revenue by Product
• 4.3 Radiation Oncology Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Radiation Oncology Breakdown Data by End User

6 North America

• 6.1 North America Radiation Oncology by Countries
  • 6.1.1 North America Radiation Oncology Sales by Countries
  • 6.1.2 North America Radiation Oncology Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Radiation Oncology by Product
• 6.3 North America Radiation Oncology by End User

7 Europe

• 7.1 Europe Radiation Oncology by Countries
  • 7.1.1 Europe Radiation Oncology Sales by Countries
  • 7.1.2 Europe Radiation Oncology Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Radiation Oncology by Product
• 7.3 Europe Radiation Oncology by End User

8 Asia Pacific

• 8.1 Asia Pacific Radiation Oncology by Countries
  • 8.1.1 Asia Pacific Radiation Oncology Sales by Countries
  • 8.1.2 Asia Pacific Radiation Oncology Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Radiation Oncology by Product
• 8.3 Asia Pacific Radiation Oncology by End User

9 Central & South America

• 9.1 Central & South America Radiation Oncology by Countries
  • 9.1.1 Central & South America Radiation Oncology Sales by Countries
  • 9.1.2 Central & South America Radiation Oncology Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Radiation Oncology by Product
• 9.3 Central & South America Radiation Oncology by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Radiation Oncology by Countries
  • 10.1.1 Middle East and Africa Radiation Oncology Sales by Countries
  • 10.1.2 Middle East and Africa Radiation Oncology Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Radiation Oncology by Product
• 10.3 Middle East and Africa Radiation Oncology by End User

11 Company Profiles

• 11.1 Accuray
  • 11.1.1 Accuray Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Accuray Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Accuray Radiation Oncology Products Offered
  • 11.1.5 Accuray Recent Development
• 11.2 C. R. Bard
  • 11.2.1 C. R. Bard Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 C. R. Bard Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 C. R. Bard Radiation Oncology Products Offered
  • 11.2.5 C. R. Bard Recent Development
• 11.3 Elekta
  • 11.3.1 Elekta Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Elekta Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Elekta Radiation Oncology Products Offered
  • 11.3.5 Elekta Recent Development
• 11.4 IBA Worldwide
  • 11.4.1 IBA Worldwide Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 IBA Worldwide Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 IBA Worldwide Radiation Oncology Products Offered
  • 11.4.5 IBA Worldwide Recent Development
• 11.5 Varian Medical Systems
  • 11.5.1 Varian Medical Systems Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Varian Medical Systems Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Varian Medical Systems Radiation Oncology Products Offered
  • 11.5.5 Varian Medical Systems Recent Development
• 11.6 Carl Zeiss Meditec
  • 11.6.1 Carl Zeiss Meditec Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Carl Zeiss Meditec Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Carl Zeiss Meditec Radiation Oncology Products Offered
  • 11.6.5 Carl Zeiss Meditec Recent Development
• 11.7 iCAD
  • 11.7.1 iCAD Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 iCAD Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 iCAD Radiation Oncology Products Offered
  • 11.7.5 iCAD Recent Development
• 11.8 IsoRay
  • 11.8.1 IsoRay Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 IsoRay Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 IsoRay Radiation Oncology Products Offered
  • 11.8.5 IsoRay Recent Development
• 11.9 Mevion Medical Systems
  • 11.9.1 Mevion Medical Systems Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Mevion Medical Systems Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Mevion Medical Systems Radiation Oncology Products Offered
  • 11.9.5 Mevion Medical Systems Recent Development
• 11.10 Nordion
  • 11.10.1 Nordion Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Nordion Radiation Oncology Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Nordion Radiation Oncology Products Offered
  • 11.10.5 Nordion Recent Development
• 11.11 NTP Radioisotopes
• 11.12 Toshiba Medical Systems

12 Future Forecast

• 12.1 Radiation Oncology Market Forecast by Regions
  • 12.1.1 Global Radiation Oncology Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Radiation Oncology Revenue Forecast by Regions 2019-2025
• 12.2 Radiation Oncology Market Forecast by Product
  • 12.2.1 Global Radiation Oncology Sales Forecast by Product 2019-2025
  • 12.2.2 Global Radiation Oncology Revenue Forecast by Product 2019-2025
• 12.3 Radiation Oncology Market Forecast by End User
• 12.4 North America Radiation Oncology Forecast
• 12.5 Europe Radiation Oncology Forecast
• 12.6 Asia Pacific Radiation Oncology Forecast
• 12.7 Central & South America Radiation Oncology Forecast
• 12.8 Middle East and Africa Radiation Oncology Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Radiation Oncology Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Radiation Oncology market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Radiation Oncology market based on company, product type, end user and key regions.

This report studies the global market size of Radiation Oncology in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiation Oncology in these regions.
This research report categorizes the global Radiation Oncology market by top players/brands, region, type and end user. This report also studies the global Radiation Oncology market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Accuray
C. R. Bard
Elekta
IBA Worldwide
Varian Medical Systems
Carl Zeiss Meditec
iCAD
IsoRay
Mevion Medical Systems
Nordion
NTP Radioisotopes
Toshiba Medical Systems

Market size by Product
External Beam Radiation Therapy (EBRT)
Brachytherapy
Market size by End User
Blood Cancer (Leukaemia)
Breast Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Skin Cancer
Other Cancers

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Radiation Oncology market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Radiation Oncology market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Radiation Oncology companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Radiation Oncology submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Radiation Oncology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Radiation Oncology market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.